Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 189 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Prairie Education and Research — Springfield, Illinois (2.2 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction, Concentric Hypertrophy
N/A
Interventional 105 participants sought
Prairie Education and Research Cooperative-St. John's — Springfield, Illinois (2.2 mi)
· Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy
Iron-deficiency Anemia (IDA), Pregnancy
Phase 4
Interventional 120 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Southern Illinois University
Renal Pelvic Denervation Pilot Trial
Uncontrolled Hypertension
N/A
Interventional 60 participants sought
SIU School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Verve Medical, Inc
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3
Interventional 562 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: SWOG Cancer Research Network
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Simmons Cancer Institute at SIU — Springfield, Illinois (2.2 mi)
· Sponsor: Eli Lilly and Company
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Springfield Clinic LLP — Springfield, Illinois (2.2 mi)
· Sponsor: Gilead Sciences
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Prairie Cardiovascular Consultants, Ltd. — Springfield, Illinois (2.2 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia
Phase 3
Interventional 170 participants sought
Springfield Clinic - First /ID# 270145 — Springfield, Illinois (2.2 mi)
· Sponsor: AbbVie
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: NRG Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Rural Illinois Lung Cancer Screening Initiative
Lung Cancer
N/A
Observational 10,000 participants sought
Sowmy Thuppal — Springfield, Illinois (2.2 mi)
· Sponsor: Southern Illinois University
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Springfield Clinic — Springfield, Illinois (2.2 mi)
· Sponsor: Boehringer Ingelheim
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Southern Illinois University-Simmons — Springfield, Illinois (2.2 mi)
· Sponsor: BriaCell Therapeutics Corporation
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Myelodysplastic Syndrome
Phase 2
Interventional 54 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Metastatic Colorectal Cancer
Phase 3
Interventional 1,020 participants sought
Springfield Clinic — Springfield, Illinois (2.2 mi)
· Sponsor: EMD Serono Research & Development Institute, Inc.
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Treatment Resistant Depression
N/A
Interventional 6,800 participants sought
Southern Illinois University School of Medicine — Springfield, Illinois (2.2 mi)
· Sponsor: LivaNova